Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Measles and Rubella Combined Vaccine,Live

Home DrugsMeasles and Rubella Combined Vaccine,Live

Measles and Rubella Combined Vaccine,Live

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Indications

用于预防麻疹和风疹。接种对象为8月龄以上的麻疹和风疹易感者。全年均适宜接种。接种本疫苗后，可刺激机体产生抗麻疹病毒和风疹病毒的免疫力。

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Preparation method of combined attenuated live vaccine of measles, parotitis and rubella
Applicant: SHANGHAI INST OF BIOLOG PRODUCPriority: 2007
CN
Gill wind varicella combined attenuated live vaccine
Applicant: SHANGHAI INST OF BIOLOGICAL PRODUCTS CO LTDPriority: 2019
CN